FINANCIAL STATEMENT ANALYSIS

USED BY US DEPARTMENT OF EDUCATION, UNIVERSITIES, STUDENTS & ACCOUNTING PRO'S

VentureLine tracks and provides 5-year financial statement analysis on approximately 7,000+ publicly traded companies; the SEC-traceable data is updated weekly. For your convenience you can access that current company financial statement analysis information by clicking directly on the Company Name, visit their Website or enter the Company name or Ticker symbol, e.g. enter 'Microsoft' or 'MSFT' for Microsoft, in the Company Search window below.

FINANCIAL STATEMENT ANALYSIS UPDATED: MARCH 29, 2020

Results 1 through 11 of 11

IN VITRO AND IN VIVO DIAGNOSTIC SUBSTANCES - SIC # 2835

Ticker Exchange Company Financial Reports SIC #
ABMC Over the counter American Bio Medica Corporatio 2835
CEMI Nasdaq Chembio Diagnostics Inc 2835
EXAS Nasdaq EXACT Sciences Corporation 2835
GH Nasdaq Guardant Health Inc 2835
IGAP Over the counter Integrity Applications Inc 2835
NTRA Nasdaq Natera Inc 2835
OSUR Nasdaq OraSure Technologies, Inc. 2835
QDEL Nasdaq Quidel Corporation 2835
QTXB Over the counter Quantrx Biomedical Corporation 2835
TRIB Nasdaq Trinity Biotech plc (ADR) 2835
VRML Nasdaq Vermillion, Inc. 2835
Results 0 through 11 of 11